Autism is not a disease and, therefore can not be cured. What we can do, however, is to learn more about it and gain an understanding of it. In this video, Timo, a young boy diagnosed with Autism, will help us understand how living with a neurodivergent mind can be.
Here are 3 must see autism products that you probably didn’t know existed
Pierce and Melissa McKay are a mother and son living in Brentwood, Tennessee, just outside Nashville. When the COVID pandemic began, the McKays found themselves without the vital school and community resources Pierce needed to navigate life as an autistic adult. They share their Brief But Spectacular take on adapting to new challenges while living with autism.
Brain changes in autism are comprehensive throughout the cerebral cortex rather than just particular areas thought to affect social behaviour and language, according to a new UCLA-led study that significantly refines scientists’ understanding of how autism ) progresses at the molecular level.
The study, published today in Nature, represents a comprehensive effort to characterize autism at the molecular level. While neurological disorders like Alzheimer’s disease or Parkinson’s disease have well-defined pathologies, autism and other psychiatric disorders lack defining pathology, making it difficult to develop more effective treatments.
The new study finds brain-wide changes in virtually all of the 11 cortical regions analyzed, regardless of whether they are higher critical association regions – those involved in functions such as reasoning, language, social cognition and mental flexibility – or primary sensory regions.
“This work represents the culmination of more than a decade of work of many lab members, which was necessary to perform such a comprehensive analysis of the autism brain,” said study author Dr. Daniel Geschwind, the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at UCLA. “We now finally are beginning to get a picture of the state of the brain, at the molecular level, of the brain in individuals who had a diagnosis of autism. This provides us with a molecular pathology, which, similar to other brain disorders such as Parkinson’s, Alzheimer’s and stroke, provides a key starting point for understanding the disorder’s mechanisms, which will inform and accelerate the development of disease-altering therapies.”
Just over a decade ago, Geschwind led the first effort to identify autism’s molecular pathology by focusing on two brain regions, the temporal lobe and the frontal lobe. Those regions were chosen because they are higher-order association regions involved in higher cognition – especially social cognition, disrupted in autism.
For the new study, researchers examined gene expression in 11 cortical regions by sequencing RNA from each of the four main cortical lobes. They compared brain tissue samples obtained after death from 112 people with ASD against healthy brain tissue.
While each profiled cortical region showed changes, the largest drop off in gene levels was in the visual cortex and the parietal cortex, which processes information like touch, pain and temperature. The researchers said this might reflect the sensory hypersensitivity frequently reported in people with autism. Researchers found strong evidence that the genetic risk for autism is enriched in a specific neuronal module that has lower expression across the brain, indicating that RNA changes in the brain are likely the cause of autism rather than a result of the disorder.
One of the next steps is to determine whether researchers can use computational approaches to develop therapies based on reversing gene expression changes the researchers found in autism, Geschwind said, adding that researchers can use organoids to model the changes to better understand their mechanisms.
